Nurse-led Educational Intervention on Heart Failure Patients

July 28, 2022 updated by: Maria Thodi, Attikon Hospital

The Effect of a Nurse-led Educational Intervention on Self-management and Prognosis of Patients With Heart Failure

A randomized controlled study to examine the effect of a nurse-led, home/telephone or telephone-only educational intervention on outcomes of heart failure patients and their caregivers.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Attica
      • Chaidari, Attica, Greece, 12461
        • Attikon University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Written informed consent
  • Men or women aged ≥18 years old.
  • Hospitalized for new-onset or decompensated chronic heart failure.

Exclusion Criteria:

  • Any severe neuromuscular disease or other disability or mobility problems that preclude performance of six-minute walk test.
  • Any severe cognitive dysfunction or psychiatric disease that limit ability to receive education.
  • Patients unable to be contacted by phone or other means.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group 1
Heart failure educational sessions will be provided by the heart failure-trained nurse to patients and caregivers. These will be delivered through a combination of home visits and telephone calls performed at regular time intervals for a total period of 6 months.
Educational intervention constitutes of a face-to-face session delivered before hospital discharge and outpatient sessions on regular intervals for a total of 6 months. Outpatient sessions in Intervention group 1 constitute of two home-based sessions on months 1 and 3, combined with weekly telephone calls during month 1 and bi-weekly calls during months 2-6. Outpatient sessions in Intervention group-2 constitute of weekly telephone sessions during month 1 and bi-weekly calls during months 2-6. The pre-discharge session will address self-monitoring and health awareness. Education will be provided by in-person discussion and through printed supporting material. Caregiver education will include understanding heart failure and advice on how to support their patient, manage their own health and well-being and how to get help when needed. During outpatient sessions, repeat education will be done and evaluation of implementation of self-care activities.
Experimental: Intervention group 2
Heart failure educational sessions will be provided by the heart failure-trained nurse to patients and caregivers. These will be delivered through telephone calls performed at regular time intervals for a total period of 6 months.
Educational intervention constitutes of a face-to-face session delivered before hospital discharge and outpatient sessions on regular intervals for a total of 6 months. Outpatient sessions in Intervention group 1 constitute of two home-based sessions on months 1 and 3, combined with weekly telephone calls during month 1 and bi-weekly calls during months 2-6. Outpatient sessions in Intervention group-2 constitute of weekly telephone sessions during month 1 and bi-weekly calls during months 2-6. The pre-discharge session will address self-monitoring and health awareness. Education will be provided by in-person discussion and through printed supporting material. Caregiver education will include understanding heart failure and advice on how to support their patient, manage their own health and well-being and how to get help when needed. During outpatient sessions, repeat education will be done and evaluation of implementation of self-care activities.
No Intervention: Control group
Control patients and caregivers will receive usual care for heart failure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in the Clinical Summary Score from baseline to month 6 by Kansas City Cardiomyopathy Questionnaire (KCCQ) Greek version
Time Frame: Baseline, 6 months
Baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in the Self-Care of Heart Failure Index (SCHFI) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in the European Heart Failure Self-care Behavior Scale (EHFScBS-9) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in the Dutch Heart Failure Knowledge Scale Greek version from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in the Self-rating Depression Scale-SDS (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in the Mini Mental State Examination (MMSE) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in exercise capacity (6 minute walking test - 6MWT) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Time to the first occurrence of a composite of all-cause death or heart failure hospitalization
Time Frame: Time from randomization to first occurrence (up to 6 months)
Time from randomization to first occurrence (up to 6 months)
Change in the Caregiver Guilt Questionnaire (CGQ) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change of the Heart Failure-Caregiver Questionnaire (HF-CQ) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6
Change in the EuroQol Health-Related Quality of Life Questionnaire EQ-5D three-level version (EQ-5D-3L) (Greek version) from baseline to month 6
Time Frame: Baseline, month 6
Baseline, month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gerasimos Filippatos, Professor, 2nd Department of Cardiology, Attikon University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2019

Primary Completion (Actual)

September 14, 2020

Study Completion (Actual)

September 14, 2020

Study Registration Dates

First Submitted

July 26, 2022

First Submitted That Met QC Criteria

July 28, 2022

First Posted (Actual)

July 29, 2022

Study Record Updates

Last Update Posted (Actual)

July 29, 2022

Last Update Submitted That Met QC Criteria

July 28, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Heart failure educational intervention

Subscribe